We’re currently researching a study medication that is being investigated to possibly improve the body’s response to hypothyroidism (low thyroid function) by reaching target hormone levels. This study is researching a new formula of levothyroxine to replace standard oral levothyroxine dosing in patients with hypothyroidism.

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

We’re currently researching a study medication that is being investigated to possibly improve the body’s response to hypothyroidism (low thyroid function) by reaching target hormone levels. This study is researching a new formula of levothyroxine to replace standard oral levothyroxine dosing in patients with hypothyroidism.

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

ProSciento está buscando adultos con diagnóstico de diabetes tipo 2 para participar en un estudio de investigación remunerado en San Diego, CA

No es necesario tener seguro médico para participar. ¡Comience el proceso hoy mismo! 

Para participar en este estudio de investigación remunerado, deberá completar un cuestionario telefónico sencillo de 20 minutos sobre usted y su estado de salud actual.

Usaremos esta información para averiguar si es elegible para este estudio o para cualquier otro estudio de investigación remunerado y con inscripción abierta en nuestro centro de investigación.

Nos complace responder a cualquier pregunta que pueda tener, y le proporcionaremos todos los detalles sobre el estudio durante su llamada telefónica con nuestro equipo de atención médica atento y altamente capacitado.

We are partnering with City of Hope® to look for adults living with Type 1 Diabetes to take part in their
research study to evaluate an experimental personalized immunotherapy (vaccine) for type 1 diabetes. All
study activities will take place at City of Hope® campus in Duarte, California.

The PIpepTolDC vaccine is a type of immunotherapy (a treatment that uses a person’s own immune system). The vaccine is made using your own immune cells and a beta cell protein. The vaccine may help your beta cells recover and make enough insulin to control your blood sugar levels. The vaccine may also help reduce future type 1
diabetes-related complications.

You’ll need to complete a risk-free, 20-minute phone call with one of our team members to see if you are
eligible. No health insurance is needed to participate!

If you are overweight, you may qualify to participate in a clinical research study. Volunteers may receive a stipend up to $4,150 for their time.  Your participation could last approximately 32 weeks and include up to two (4-day) in-house stays. You may also be considered for future research studies at ProSciento. Our research facility is located in Chula Vista, California. 

This study is to evaluate a new investigational medication being developed as a new option for people with Non-Alcoholic Steatohepatitis (NASH) who carry a specific gene we are looking to identify.